Endothelial periostin regulates vascular remodeling by promoting endothelial dysfunction in pulmonary arterial hypertension

References

• Abdul-Salam VB, Wharton J, Cupitt J, Berryman M, Edwards RJ, Wilkins MR. 2010. Proteomic analysis of lung tissues from patients with pulmonary arterial hypertension. Circulation. 122(20):2058–2067. doi:10.1161/CIRCULATIONAHA.110.972745.
   PubMed Web of Science ®Google Scholar
• Ambade AS, Hassoun PM, Damico RL. 2021. Basement membrane extracellular matrix proteins in pulmonary vascular and right ventricular remodeling in pulmonary hypertension. Am J Respir Cell Mol Biol. 65(3):245–258. doi:10.1165/rcmb.2021-0091TR.
   PubMed Web of Science ®Google Scholar
• Chen T, Sun MR, Zhou Q, Guzman AM, Ramchandran R, Chen J, Fraidenburg DR, Ganesh B, Maienschein-Cline M, Obrietan K, et al. 2022. MicroRNA-212-5p, an anti-proliferative miRNA, attenuates hypoxia and sugen/hypoxia-induced pulmonary hypertension in rodents. Mol Ther Nucleic Acids. 29:204–216. doi:10.1016/j.omtn.2022.06.008.
   PubMedGoogle Scholar
• Cho JG, Lee A, Chang W, Lee MS, Kim J. 2018. Endothelial to mesenchymal transition represents a Key link in the interaction between inflammation and endothelial dysfunction. Front Immunol. 9:294. doi:10.3389/fimmu.2018.00294.
   PubMed Web of Science ®Google Scholar
• Dorafshan S, Razmi M, Safaei S, Gentilin E, Madjd Z, Ghods R. 2022. Periostin: biology and function in cancer. Cancer Cell Int. 22(1):315. doi:10.1186/s12935-022-02714-8.
   PubMed Web of Science ®Google Scholar
• Duan X, Cai L, Pham CTN, Abu-Amer Y, Pan H, Brophy RH, Wickline SA, Rai MF. 2021. Amelioration of posttraumatic osteoarthritis in mice using intraarticular silencing of periostin via nanoparticle-based small interfering RNA. Arthritis Rheu. 73(12):2249–2260. doi:10.1002/art.41794.
   PubMed Web of Science ®Google Scholar
• Evans JD, Girerd B, Montani D, Wang XJ, Galie N, Austin ED, Elliott G, Asano K, Grunig E, Yan Y, et al. 2016. BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis. Lancet Resp Med. 4(2):129–137. doi:10.1016/S2213-2600(15)00544-5.
   PubMed Web of Science ®Google Scholar
• Groth A, Vrugt B, Brock M, Speich R, Ulrich S, Huber LC. 2014. Inflammatory cytokines in pulmonary hypertension. Respir Res. 15(1):47. doi:10.1186/1465-9921-15-47.
   PubMedGoogle Scholar
• Guignabert C, Humbert M. 2021. Targeting transforming growth factor-β receptors in pulmonary hypertension. Eur Respir J. 57(2)):2002341. doi:10.1183/13993003.02341-2020.
   PubMed Web of Science ®Google Scholar
• Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, Bell JC, Dedhar S. 1996. Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase. Nature. 379(6560):91–96. doi:10.1038/379091a0.
   PubMed Web of Science ®Google Scholar
• Hiepen C, Jatzlau J, Hildebrandt S, Kampfrath B, Goktas M, Murgai A, Cuellar Camacho JL, Haag R, Ruppert C, Sengle G, et al. 2019. BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGFβ responses and altered cell mechanics. PLoS Biol. 17(12):e3000557. doi:10.1371/journal.pbio.3000557.
   PubMed Web of Science ®Google Scholar
• Hopper RK, Moonen JR, Diebold I, Cao A, Rhodes CJ, Tojais NF, Hennigs JK, Gu M, Wang L, Rabinovitch M. 2016. In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug. Circulation. 133(18):1783–1794.
   PubMed Web of Science ®Google Scholar
• Hu Y, Chi L, Kuebler WM, Goldenberg NM. 2020. Perivascular inflammation in pulmonary arterial hypertension. Cells. 9(11). 2338.
   Web of Science ®Google Scholar
• Humbert M, Guignabert C, Bonnet S, Dorfmuller P, Klinger JR, Nicolls MR, Olschewski AJ, Pullamsetti SS, Schermuly RT, Stenmark KR, et al. 2019. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. Eur Respir J. 53(1):1801887. doi:10.1183/13993003.01887-2018.
   PubMed Web of Science ®Google Scholar
• Jia G, Erickson RW, Choy DF, Mosesova S, Wu LC, Solberg OD, Shikotra A, Carter R, Audusseau S, Hamid Q, et al. 2012. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol. 130(3):647–654 e610.
   PubMed Web of Science ®Google Scholar
• Jia YY, Yu Y, Li HJ. 2021. POSTN promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through ILK/AKT/mTOR pathway. J Cancer. 12(14):4183–4195. doi:10.7150/jca.51253.
   PubMed Web of Science ®Google Scholar
• Kayyali US, Pennella CM, Trujillo C, Villa O, Gaestel M, Hassoun PM. 2002. Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2. J Biol Chem. 277(45):42596–42602. doi:10.1074/jbc.M205863200.
   PubMed Web of Science ®Google Scholar
• Kii I, Nishiyama T, Kudo A. 2016. Periostin promotes secretion of fibronectin from the endoplasmic reticulum. Biochem Biophys Res Commun. 470(4):888–893. doi:10.1016/j.bbrc.2016.01.139.
   PubMed Web of Science ®Google Scholar
• Kim BR, Yoon JW, Choi H, Kim D, Kang S, Kim JH. 2022. Application of periostin peptide-decorated self-assembled protein cage nanoparticles for therapeutic angiogenesis. BMB Rep. 55(4):175–180. doi:10.5483/BMBRep.2022.55.4.137.
   PubMed Web of Science ®Google Scholar
• Kim J, Kang Y, Kojima Y, Lighthouse JK, Hu X, Aldred MA, McLean DL, Park H, Comhair SA, Greif DM, et al. 2013. An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension. Nat Med. 19(1):74–82. doi:10.1038/nm.3040.
   PubMed Web of Science ®Google Scholar
• Kudo A, Kii I. 2018. Periostin function in communication with extracellular matrices. J Cell Commun Signal. 12(1):301–308. doi:10.1007/s12079-017-0422-6.
   PubMed Web of Science ®Google Scholar
• Kudryashova TV, Goncharov DA, Pena A, Kelly N, Vanderpool R, Baust J, Kobir A, Shufesky W, Mora AL, Morelli AE, et al. 2016. HIPPO-Integrin-linked kinase cross-talk controls self-sustaining proliferation and survival in pulmonary hypertension. Am J Respir Crit Care Med. 194(7):866–877. doi:10.1164/rccm.201510-2003OC.
   PubMed Web of Science ®Google Scholar
• Kumar R, Mickael C, Chabon J, Gebreab L, Rutebemberwa A, Garcia AR, Koyanagi DE, Sanders L, Gandjeva A, Kearns MT, et al. 2015. The causal role of IL-4 and IL-13 in schistosoma mansoni pulmonary hypertension. Am J Respir Crit Care Med. 192(8):998–1008. doi:10.1164/rccm.201410-1820OC.
   PubMed Web of Science ®Google Scholar
• Kurakula K, Smolders V, Tura-Ceide O, Jukema JW, Quax PHA, Goumans MJ. 2021. Endothelial dysfunction in pulmonary hypertension: cause or consequence? Biomedicines. 9(1):57. doi:10.3390/biomedicines9010057.
   PubMed Web of Science ®Google Scholar
• Lee A, McLean D, Choi J, Kang H, Chang W, Kim J. 2014. Therapeutic implications of microRNAs in pulmonary arterial hypertension. BMB Rep. 47(6):311–317. doi:10.5483/BMBRep.2014.47.6.085.
   PubMed Web of Science ®Google Scholar
• Li P, Oparil S, Feng W, Chen YF. 2004. Hypoxia-responsive growth factors upregulate periostin and osteopontin expression via distinct signaling pathways in rat pulmonary arterial smooth muscle cells. J Appl Physiol (1985). 97(4):1550–1558; discussion 1549. doi:10.1152/japplphysiol.01311.2003.
   PubMed Web of Science ®Google Scholar
• Li P, Oparil S, Novak L, Cao X, Shi W, Lucas J, Chen YF. 2007. ANP signaling inhibits TGF-β-induced Smad2 and Smad3 nuclear translocation and extracellular matrix expression in rat pulmonary arterial smooth muscle cells. J Appl Physiol (1985). 102(1):390–398. doi:10.1152/japplphysiol.00468.2006.
   PubMed Web of Science ®Google Scholar
• Ling X, Peng S, Xu Y, Chu F. 2022. Beneficial effect of simvastatin on human umbilical vein endothelial cells gap junctions induced by TNF-α. Animal Cells Syst (Seoul). 26(1):10–18. doi:10.1080/19768354.2021.2023037.
   PubMed Web of Science ®Google Scholar
• Liu S-F, Nambiar Veetil N, Li Q, Kucherenko MM, Knosalla C, Kuebler WM. 2022. Pulmonary hypertension: linking inflammation and pulmonary arterial stiffening. Front Immunol. 13:959209. doi:10.3389/fimmu.2022.959209.
   PubMed Web of Science ®Google Scholar
• Ma Z, Zhao X, Deng M, Huang Z, Wang J, Wu Y, Cui D, Liu Y, Liu R, Ouyang G. 2019. Bone marrow mesenchymal stromal cell-derived periostin promotes B-ALL progression by modulating CCL2 in leukemia cells. Cell Rep. 26(6):1533–1543 e1534. doi:10.1016/j.celrep.2019.01.034.
   PubMed Web of Science ®Google Scholar
• Maleszewska M, Moonen JR, Huijkman N, van de Sluis B, Krenning G, Harmsen MC. 2013. IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner. Immunobiology. 218(4):443–454. doi:10.1016/j.imbio.2012.05.026.
   PubMed Web of Science ®Google Scholar
• Monteiro JP, Rodor J, Caudrillier A, Scanlon JP, Spiroski AM, Dudnakova T, Pfluger-Muller B, Shmakova A, von Kriegsheim A, Deng L, et al. 2021. Mir503hg loss promotes endothelial-to-mesenchymal transition in vascular disease. Circ Res. 128(8):1173–1190. doi:10.1161/CIRCRESAHA.120.318124.
   PubMed Web of Science ®Google Scholar
• Naik PK, Bozyk PD, Bentley JK, Popova AP, Birch CM, Wilke CA, Fry CD, White ES, Sisson TH, Tayob N, et al. 2012. Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am J Physiol-Lung C. 303(12):L1046–L1056. doi:10.1152/ajplung.00139.2012.
   PubMed Web of Science ®Google Scholar
• Nie L, Lyros O, Medda R, Jovanovic N, Schmidt JL, Otterson MF, Johnson CP, Behmaram B, Shaker R, Rafiee P. 2014. Endothelial-mesenchymal transition in normal human esophageal endothelial cells cocultured with esophageal adenocarcinoma cells: role of IL-1β and TGF-β2. Am J Physiol-Cell Physiol. 307(9):C859–C877. doi:10.1152/ajpcell.00081.2014.
   PubMed Web of Science ®Google Scholar
• Nie X, Shen C, Tan J, Wu Z, Wang W, Chen Y, Dai Y, Yang X, Ye S, Chen J, et al. 2020. Periostin: A Potential Therapeutic Target For Pulmonary Hypertension?. Circ Res. 127(9):1138–1152. doi:10.1161/CIRCRESAHA.120.316943.
   PubMed Web of Science ®Google Scholar
• Nikoloudaki G, Snider P, Simmons O, Conway SJ, Hamilton DW. 2020. Periostin and matrix stiffness combine to regulate myofibroblast differentiation and fibronectin synthesis during palatal healing. Matrix Biol. 94:31–56. doi:10.1016/j.matbio.2020.07.002.
   PubMed Web of Science ®Google Scholar
• Oka T, Xu J, Kaiser RA, Melendez J, Hambleton M, Sargent MA, Lorts A, Brunskill EW, Dorn GW, Conway SJ, et al. 2007. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circ Res. 101(3):313–321. doi:10.1161/CIRCRESAHA.107.149047.
   PubMed Web of Science ®Google Scholar
• Prasain N, Stevens T. 2009. The actin cytoskeleton in endothelial cell phenotypes. Microvasc Res. 77(1):53–63. doi:10.1016/j.mvr.2008.09.012.
   PubMed Web of Science ®Google Scholar
• Pugliese SC, Poth JM, Fini MA, Olschewski A, El Kasmi KC, Stenmark KR. 2015. The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes. Am J Physiol-Lung C. 308(3):L229–L252. doi:10.1152/ajplung.00238.2014.
   PubMed Web of Science ®Google Scholar
• Rafikov R, Rischard F, Vasilyev M, Varghese MV, Yuan JX, Desai AA, Garcia JGN, Rafikova O. 2022. Cytokine profiling in pulmonary arterial hypertension: the role of redox homeostasis and sex. Transl Res. 247:1–18. doi:10.1016/j.trsl.2022.03.013.
   PubMed Web of Science ®Google Scholar
• Raman A, Parnell SC, Zhang Y, Reif GA, Dai Y, Khanna A, Daniel E, White C, Vivian JL, Wallace DP. 2018. Periostin overexpression in collecting ducts accelerates renal cyst growth and fibrosis in polycystic kidney disease. Am J Physiol-Renal. 315(6):F1695–F1707. doi:10.1152/ajprenal.00246.2018.
   PubMed Web of Science ®Google Scholar
• Raman A, Reif GA, Dai Y, Khanna A, Li X, Astleford L, Parnell SC, Calvet JP, Wallace DP. 2017. Integrin-Linked kinase signaling promotes cyst growth and fibrosis in polycystic kidney disease. J Am Soc Nephrol. 28(9):2708–2719. doi:10.1681/ASN.2016111235.
   PubMed Web of Science ®Google Scholar
• Ranchoux B, Antigny F, Rucker-Martin C, Hautefort A, Pechoux C, Bogaard HJ, Dorfmuller P, Remy S, Lecerf F, Plante S, et al. 2015. Endothelial-to-mesenchymal transition in pulmonary hypertension. Circulation. 131(11):1006–1018. doi:10.1161/CIRCULATIONAHA.114.008750.
   PubMed Web of Science ®Google Scholar
• Ranchoux B, Harvey LD, Ayon RJ, Babicheva A, Bonnet S, Chan SY, Yuan JX, Perez VJ. 2018. Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series). Pulm Circ. 8(1):1–17. doi:10.1177/2045893217752912.
   Web of Science ®Google Scholar
• Rol N, Kurakula KB, Happe C, Bogaard HJ, Goumans MJ. 2018. TGF-beta and BMPR2 signaling in PAH: two black sheep in one family. Int J Mol Sci. 19(9):2585.
   PubMed Web of Science ®Google Scholar
• Romero LI, Zhang DN, Herron GS, Karasek MA. 1997. Interleukin-1 induces major phenotypic changes in human skin microvascular endothelial cells. J Cell Physiol. 173(1):84–92. doi:10.1002/(SICI)1097-4652(199710)173:1<84::AID-JCP10>3.0.CO;2-N.
   PubMed Web of Science ®Google Scholar
• Ruopp NF, Cockrill BA. 2022. Diagnosis and treatment of pulmonary arterial hypertension. JAMA. 327(14):1379–1391. doi:10.1001/jama.2022.4402.
   PubMed Web of Science ®Google Scholar
• Russomanno G, Jo KB, Abdul-Salam VB, Morgan C, Endruschat J, Schaeper U, Osman AH, Alzaydi MM, Wilkins MR, Wojciak-Stothard B. 2021. miR-150-PTPMT1-cardiolipin signaling in pulmonary arterial hypertension. Mol Ther - Nucleic Acids. 23:142–153. doi:10.1016/j.omtn.2020.10.042.
   Google Scholar
• Seki M, Furukawa N, Koitabashi N, Obokata M, Conway SJ, Arakawa H, Kurabayashi M. 2019. Periostin-expressing cell-specific transforming growth factor-β inhibition in pulmonary artery prevents pulmonary arterial hypertension. PLoS One. 14(8):e0220795. doi:10.1371/journal.pone.0220795.
   PubMed Web of Science ®Google Scholar
• Shen Y, Goncharov DA, Avolio T, Ray A, Okorie E, DeLisser H, Mora AL, Vanderpool R, Kudryashova TV, Goncharova EA. 2020. Differential effects of integrin-linked kinase inhibitor Cpd22 on severe pulmonary hypertension in male and female rats. Pulm Circ. 10(1):1–12. doi:10.1177/2045894019898593.
   Web of Science ®Google Scholar
• Sidhu SS, Yuan S, Innes AL, Kerr S, Woodruff PG, Hou L, Muller SJ, Fahy JV. 2010. Roles of epithelial cell-derived periostin in TGF-β activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci USA. 107(32):14170–14175. doi:10.1073/pnas.1009426107.
   PubMed Web of Science ®Google Scholar
• Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. 2019. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 53(1):1801913. doi:10.1183/13993003.01913-2018.
   PubMed Web of Science ®Google Scholar
• Snider P, Hinton RB, Moreno-Rodriguez RA, Wang J, Rogers R, Lindsley A, Li F, Ingram DA, Menick D, Field L, et al. 2008. Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circ Res. 102(7):752–760. doi:10.1161/CIRCRESAHA.107.159517.
   PubMed Web of Science ®Google Scholar
• Soon E, Holmes AM, Treacy CM, Doughty NJ, Southgate L, Machado RD, Trembath RC, Jennings S, Barker L, Nicklin P, et al. 2010. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation. 122(9):920–927. doi:10.1161/CIRCULATIONAHA.109.933762.
   PubMed Web of Science ®Google Scholar
• Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA, Waxman AB. 2009. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res. 104(2):236–244, 236p following 244. doi:10.1161/CIRCRESAHA.108.182014.
   PubMed Web of Science ®Google Scholar
• Stenmark KR, Fagan KA, Frid MG. 2006. Hypoxia-Induced pulmonary vascular remodeling. Circ Res. 99(7):675–691. doi:10.1161/01.RES.0000243584.45145.3f.
   PubMed Web of Science ®Google Scholar
• Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF. 2009. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol-Lung C. 297(6):L1013–L1032. doi:10.1152/ajplung.00217.2009.
   PubMed Web of Science ®Google Scholar
• Takagi K, Yamakuchi M, Matsuyama T, Kondo K, Uchida A, Misono S, Hashiguchi T, Inoue H. 2018. IL-13 enhances mesenchymal transition of pulmonary artery endothelial cells via down-regulation of miR-424/503 in vitro. Cell Signal. 42:270–280. doi:10.1016/j.cellsig.2017.10.019.
   PubMed Web of Science ®Google Scholar
• Teichert-Kuliszewska K, Kutryk MJ, Kuliszewski MA, Karoubi G, Courtman DW, Zucco L, Granton J, Stewart DJ. 2006. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension. Circ Res. 98(2):209–217. doi:10.1161/01.RES.0000200180.01710.e6.
   PubMed Web of Science ®Google Scholar
• Thenappan T, Chan SY, Weir EK. 2018. Role of extracellular matrix in the pathogenesis of pulmonary arterial hypertension. Am J Physiol-Heart C. 315(5):H1322–H1331. doi:10.1152/ajpheart.00136.2018.
   PubMed Web of Science ®Google Scholar
• Tu L, Dewachter L, Gore B, Fadel E, Dartevelle P, Simonneau G, Humbert M, Eddahibi S, Guignabert C. 2011. Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension. Am J Respir Cell Mol Biol. 45(2):311–322. doi:10.1165/rcmb.2010-0317OC.
   PubMed Web of Science ®Google Scholar
• Unenkhuu B, Kim DB, Kim HS. 2021. MKP-3 suppresses LPS-induced inflammatory responses in HUVECs via inhibition of p38 MAPK/NF-κB pathway. Animal Cells Syst (Seoul). 25(4):235–244. doi:10.1080/19768354.2021.1954551.
   PubMed Web of Science ®Google Scholar
• Wang J, Niu Y, Luo L, Lu Z, Chen Q, Zhang S, Guo Q, Li L, Gou D. 2022. Decoding ceRNA regulatory network in the pulmonary artery of hypoxia-induced pulmonary hypertension (HPH) rat model. Cell Biosci. 12(1):27. doi:10.1186/s13578-022-00762-1.
   PubMed Web of Science ®Google Scholar
• Wang XD, Li F, Ma DB, Deng X, Zhang H, Gao J, Hao L, Liu DD, Wang J. 2016. Periostin mediates cigarette smoke extract-induced proliferation and migration in pulmonary arterial smooth muscle cells. Biomed Pharmacother. 83:514–520. doi:10.1016/j.biopha.2016.07.007.
   PubMed Web of Science ®Google Scholar
• Wani AA, Jafarnejad SM, Zhou J, Li G. 2011. Integrin-linked kinase regulates melanoma angiogenesis by activating NF-κB/interleukin-6 signaling pathway. Oncogene. 30(24):2778–2788. doi:10.1038/onc.2010.644.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Yasue A, Fujihara S, Tanaka E. 2012. PERIOSTIN regulates MMP-2 expression via the αvβ3 integrin/ERK pathway in human periodontal ligament cells. Arch Oral Biol. 57(1):52–59. doi:10.1016/j.archoralbio.2011.07.010.
   PubMed Web of Science ®Google Scholar
• Wei T, Wang K, Liu S, Fang Y, Hong Z, Liu Y, Zhang H, Yang C, Ouyang G, Wu T. 2023. Periostin deficiency reduces PD-1+ tumor-associated macrophage infiltration and enhances anti-PD-1 efficacy in colorectal cancer. Cell Rep. 42(2):112090. doi:10.1016/j.celrep.2023.112090.
   PubMed Web of Science ®Google Scholar
• Wu C, Dedhar S. 2001. Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol. 155(4):505–510. doi:10.1083/jcb.200108077.
   PubMed Web of Science ®Google Scholar
• Xue C, Senchanthisai S, Sowden M, Pang J, White RJ, Berk BC. 2020. Endothelial-to-Mesenchymal transition and inflammation play Key roles in cyclophilin A-induced pulmonary arterial hypertension. Hypertension. 76(4):1113–1123. doi:10.1161/HYPERTENSIONAHA.119.14013.
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Ono J, Masuoka M, Ohta S, Izuhara K, Ikezawa Z, Aihara M, Takahashi K. 2013. Serum periostin levels are correlated with progressive skin sclerosis in patients with systemic sclerosis. Br J Dermatol. 168(4):717–725. doi:10.1111/bjd.12117.
   PubMed Web of Science ®Google Scholar
• Yeo Y, Jeong H, Kim M, Choi Y, Kim KL, Suh W. 2022. Crosstalk between BMP signaling and KCNK3 in phenotypic switching of pulmonary vascular smooth muscle cells. BMB Rep. 55(11):565–570. doi:10.5483/BMBRep.2022.55.11.098.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Nagaoka T, Nagata Y, Suzuki Y, Tsutsumi T, Kuriyama S, Watanabe J, Togo S, Takahashi F, Matsushita M, et al. 2022. Periostin-related progression of different types of experimental pulmonary hypertension: a role for M2 macrophage and FGF-2 signalling. Respirology. 27(7):529–538. doi:10.1111/resp.14249.
   PubMed Web of Science ®Google Scholar
• Yun E, Kook Y, Yoo KH, Kim KI, Lee MS, Kim J, Lee A. 2020. Endothelial to mesenchymal transition in pulmonary vascular diseases. Biomedicines. 8(12).
   Web of Science ®Google Scholar
• Yun E, Kwon BS, Kim J, Lee A. 2023. Ginsenoside Rg3 attenuates pulmonary fibrosis by inhibiting endothelial to mesenchymal transition. Animal Cells Syst (Seoul). 27(1):159–170. doi:10.1080/19768354.2023.2244549.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Peng J, Lu C, Hsin M, Mura M, Wu L, Chu L, Zamel R, Machuca T, Waddell T, et al. 2014. Metabolomic heterogeneity of pulmonary arterial hypertension. PLoS One. 9(2):e88727. doi:10.1371/journal.pone.0088727.
   PubMed Web of Science ®Google Scholar
• Zheng QM, Lu JJ, Zhao J, Wei X, Wang L, Liu PS. 2016. Periostin facilitates the epithelial-mesenchymal transition of endometrial epithelial cells through ILK-Akt signaling pathway. Biomed Res Int. 2016:9842619.
   PubMed Web of Science ®Google Scholar